Browsing Category
Lipids
Effect of double coating on microencapsulation of levofloxacin using the particles from…
Abstract
A novel double-coating technique was employed to encapsulate levofloxacin (LVF), a potent antibacterial drug, using the particles from gas-saturated solutions (PGSS) process to achieve extended release. The primary coating utilized glyceryl tristearate (GT), a lipid with a high melting…
Read More...
Read More...
Highly Increasing Solubility of Clofazimine, an Extremely Water-insoluble Basic Drug, in Lipid-based…
Abstract
Clofazimine (CFZ) is a highly effective antibiotic against leprosy and drug-resistant tuberculosis and is on the WHO List of Essential Drugs. However, no CFZ product with optimal bioavailability is available worldwide. The manufacturer withdrew its only marketed product, presumably due to…
Read More...
Read More...
Webinar series: Enhancing drug loading and bioavailability in lipid systems
Webinar series by Gattefossé and SeraNovo
Gattefossé, a worldwide supplier of lipid-based excipients for the pharmaceutical industry, collaborates with SeraNovo, a leader in proprietary formulation technology designed to enhance the bioavailability of complex molecules, to organize a series of two…
Read More...
Read More...
Clopidogrel loaded nanostructured lipid carrier: Assembly, microstructure and cytotoxicity
Here we designed an optimized NLC for the transport of CLP, an antiplatelet molecule, and further probed its microstructure, cytotoxicity and the stability. NLCs were attained through cavitation technology employing RSM-based factorial design (23). Amount of lipid (X1), ultrasound power (X2), and…
Read More...
Read More...
Trans-Resveratrol-Loaded Nanostructured Lipid Carrier Formulations for Pulmonary Drug Delivery Using…
Abstract
Aerosolization is a non-invasive approach of delivering drugs for both localized and systemic effects, specifically pulmonary targeting. The aim of this study was to deliver trans-resveratrol (TR) as an anti-cancer drug entrapped in a new generation versatile carriers nanostructured lipid…
Read More...
Read More...
Fabrication of lipid-modified drug nanocrystals loaded injectable hydrogel for breast cancer therapy
Abstract
The current study includes the design of soluplus stabilized, lipid-coated, and fucoidan-oleylamine conjugate modified paclitaxel nanocrystals. The nanocrystals (Lipid-NCs) were about 100 nm, homogeneous, stable and showed improved drug release compared to pure PTX. The nanocrystals were…
Read More...
Read More...
Multi spectroscopic investigation of maisine-based microemulsions as convenient carriers for…
Abstract
Lipid-based drug delivery systems are very promising in addressing critical medical needs associated with cancer because they are able to enhance the efficacy of the therapeutic agents loaded in. Yet, their transferability from bench to bedside is still a challenge as it hits many…
Read More...
Read More...
Acyl chitosan based self-nanoemulsifying drug delivery system of lipophilic drug with enhanced oral…
Abstract
This study developed a mucoadhesive self-nano emulsifying drug delivery system (SNEDDS) with synthesized acyl chitosan coating for enhancing oral bioavailability and drug retention of Amphotericin B (AB) which is conventionally administered parenterally owing to its poor bioavailability.…
Read More...
Read More...
Enhancing the Photothermal Properties of Indocyanine Green in Melanoma Spheroids via Encapsulation…
Abstract
Indocyanine green (ICG), a well-known photosensitiser, has shown potential in photothermal therapy (PTT) for cancer treatment, but its effectiveness is limited by poor skin penetration and rapid clearance. To address this, lipid nanocapsules (LNCs) were used as nanocarriers to enhance…
Read More...
Read More...
Archaeosomes facilitate storage and oral delivery of cannabidiol
Cannabidiol (CBD) has received great scientific interest due to its numerous therapeutic applications. Degradation in the gastrointestinal (GI) tract, first-pass metabolism, and low water solubility restrain bioavailability of CBD to only 6% in current oral administration. Lipid-based nanocarriers…
Read More...
Read More...